Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Could surrogate indexes identify insulin resistant individuals among women with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: Surrogate indexes may be able to rule in, but not rule out, insulin resistance in women with PCOS. WHAT IS KNOWN ALREADY: Insulin resistance is a typical finding of women with PCOS and most clinical information on this issue is based upon surrogate indexes of insulin resistance. However, data on the performance of these indexes in PCOS women are very limited. STUDY DESIGN SIZE, DURATION: A retrospective analysis of 406 women referred to our outpatient clinic for hyperandrogenism and/or menstrual dysfunction and submitted to hyperinsulinemic euglycaemic clamp between 1998 and 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: In total, 375 of these women had PCOS by the Rotterdam criteria and were included in the study. Six surrogate indexes of insulin sensitivity were calculated from glucose and insulin levels, either at fasting (homeostasis model assessment (HOMA), glucose/insulin (G/I) ratio and quantitative insulin sensitivity check index (QUICKI)) or after oral glucose load (Gutt, Stumvoll0-120 and Matsuda). MAIN RESULTS AND THE ROLE OF CHANCE: Overall, insulin resistance, as identified by the M-clamp value, was found in 74.9% of these women. The percentage was 59.3% in normal-weight vs 77.5% in overweight and 93.9% in obese subjects. All surrogate indexes were highly correlated with the M-clamp values. However, their ability to identify insulin resistant individuals was limited, in terms of sensitivity and especially in normal-weight subjects. ROC analysis showed similar performances of these indexes (AUC values 0.782-0.817). LIMITATIONS REASONS FOR CAUTION: Potential referral bias of PCOS patients may have caused overestimation of the prevalence of insulin resistance in these women. WIDER IMPLICATIONS OF THE FINDINGS: By using surrogate indexes many subjects with PCOS may be erroneously diagnosed as insulin sensitive, especially among normal-weight women. These indexes can be used to rule in, but not rule out, insulin resistance in PCOS. STUDY FUNDING/COMPETING INTEREST(S): Academic grants to P. Moghetti from the University of Verona. All authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with nearly 75% of individuals with PCOS estimated to have some degree of insulin resistance [27].”
From Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [27]
In the citing paper
“Insulin resistance appears to be a large driver of these risk factors”
From Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [27]
In the citing paper
“In actual fact, they are more valuable in ruling in rather than ruling out insulin resistance in PCOS, especially among normal weight women [43].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [43]
In the citing paper
“In PCOS, IR is present in obese and overweight patients, as well as in those of normal weight, although in the latter group, with a lower frequency (59.3% in normal weight vs. 77.5% in overweight and 93.9% in obese patients) [33].”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [33]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860 · cited 1×
“Diagnosis of metabolic syndrome was carried out using the 2009 joint criteria by the International Diabetes Federation (IDF) and other Societies (Alberti et al., 2009).”
Method(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“Glucose disposal rate during the steady-state period of the clamp (M-clamp) was calculated with standard formula (DeFronzo et al., 1979).”
MethodMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“…in other clinical conditions, suggested that surrogate indexes derived from the OGTT could perform better, as compared with those obtained from fasting values (Matsuda and DeFronzo, 1999; Gutt et al., 2000; Stumvoll et al., 2001), although the amount of additional information may indeed be limited.”
BackgroundKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 1×
“Because muscle is responsible for most insulin-induced glucose metabolism (DeFronzo, 1988), glucose disposal data were expressed per fat-free mass (mg/kg FFMmin).”
BackgroundMen at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Second, insulin resistance plays a crucial role in the pathogenesis of PCOS itself (Diamanti-Kandarakis and Dunaif, 2012).”
BackgroundHirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,014 · cited 2×
“Clinical hyperandrogenism was defined by the presence of hirsutism (modified Ferriman–Gallwey score ≥8) (Hatch et al., 1981) and/or acne and/or alopecia; biochemical hyperandrogenism was defined by increased levels of at least one serum androgen (total or free testosterone, androstenedione or dehydroepiandrosterone su…”
BackgroundLegro, R. S., Finegood, D., & Dunaif, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5054 · Cited by 673 · cited 1×
“Indeed, very few studies, all based on fasting data, performed these analyses in women with PCOS, with conflicting results (Legro et al., 1998; Ducluzeau et al., 2003; Diamanti-Kandarakis et al., 2004; Kim et al., 2006).”
BackgroundHow to measure insulin sensitivity
Ferrannini, E., & Mari, A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00001 · Cited by 512 · cited 1×
“The hyperinsulinemic euglycemic clamp is unanimously considered the gold standard to evaluate insulin sensitivity in vivo (Ferrannini and Mari, 1988).”
BackgroundValidation of the insulin sensitivity index (ISI0,120): comparison with other measures
Gutt, M., Davis, C. L., Spitzer, S. B., Llabre, M. M., Kumar, M., Czarnecki, E. M., Schneiderman, N., Skyler, J. S., & Marks, J. B. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00116-3 · Cited by 474 · cited 2×
“…in other clinical conditions, suggested that surrogate indexes derived from the OGTT could perform better, as compared with those obtained from fasting values (Matsuda and DeFronzo, 1999; Gutt et al., 2000; Stumvoll et al., 2001), although the amount of additional information may indeed be limited.”
BackgroundCassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415 · cited 2×
“A meta-analysis of clamp studies concluded that the impairment in insulin action is intrinsic to PCOS and independent of BMI, although obesity exacerbates insulin resistance with a disproportionately greater effect in these women than in controls (Cassar et al., 2016).”
BackgroundResultStumvoll, M., Van Haeften, T., Fritsche, A., & Gerich, J. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.796 · Cited by 308
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262 · cited 3×
“The cut-off value for clamp data was determined from historical data of healthy subjects with similar characteristics, as previously described (Moghetti et al., 2013).”
MethodResultInfluentialSelf-citationChang, R. J., Heindel, J. J., & Dunaif, A. (2002) · CRC Press eBooks · doi:10.3109/9780203910948 · Cited by 262
Moghetti, P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.952 · Cited by 245 · cited 2×
“The hyperinsulinemic euglycemic clamp was performed as previously described (Moghetti et al., 1996), at an insulin infusion rate of 80mU/m(2)min.”
MethodSelf-citationReferral Bias in Defining the Phenotype and Prevalence of Obesity in Polycystic Ovary Syndrome
Ezeh, U., Yildiz, B. O., & Azziz, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1295 · Cited by 193 · cited 1×
“A limitation of the study, as regards the prevalence of insulin resistance in these women, is the potential referral bias of patients investigated, which may have caused overestimation of this figure (Ezeh et al., 2013).”
BackgroundCurrent concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome
Reusch, J. E. B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02555-9 · Cited by 169 · cited 1×
“First, it is a fundamental underlying mechanism for both type 2 diabetes and metabolic syndrome (Reusch, 2002), which are recognized risk factors for cardiovascular disease.”
BackgroundDiamanti-Kandarakis, E., Kouli, C., Alexandraki, K., & Spina, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031205 · Cited by 150 · cited 3×
“Indeed, very few studies, all based on fasting data, performed these analyses in women with PCOS, with conflicting results (Legro et al., 1998; Ducluzeau et al., 2003; Diamanti-Kandarakis et al., 2004; Kim et al., 2006).”
BackgroundDucluzeau, P.-H., Cousin, P., Malvoisin, E., Bornet, H., Vidal, H., Laville, M., & Pugeat, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030219 · Cited by 137 · cited 2×
“Indeed, very few studies, all based on fasting data, performed these analyses in women with PCOS, with conflicting results (Legro et al., 1998; Ducluzeau et al., 2003; Diamanti-Kandarakis et al., 2004; Kim et al., 2006).”
BackgroundInfluentialImplications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome
Tosi, F., Fiers, T., Kaufman, J.-M., Dall'Alda, M., Moretta, R., Giagulli, V. A., Bonora, E., & Moghetti, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2807 · Cited by 67 · cited 2×
“In 232 women, investigated between 2010 and 2015, total testosterone and androstenedione were measured by liquid chromatography tandem mass spectrometry, and free testosterone fraction was assessed by equilibrium dialysis, as previously described (Tosi et al., 2016).”
MethodSelf-citationLimitations in Surrogate Measures of Insulin Resistance
Buchanan, T. A., Watanabe, R. M., & Xiang, A. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2167 · Cited by 58 · cited 1×
“Moreover, surrogate indexes should be validated in each specific setting before they can be appropriately used (Buchanan et al., 2010).”
BackgroundLangdon, D. R. (1999) · Clinical Pediatrics · doi:10.1177/000992289903800409 · Cited by 16
Kim, H.-J., Byun, E. K., Oh, J. Y., Sung, Y., & Chung, H. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.4.277 · Cited by 2
Cited by
Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
“In actual fact, they are more valuable in ruling in rather than ruling out insulin resistance in PCOS, especially among normal weight women [43].”
BackgroundCaprio, M., Infante, M., Moriconi, E., Armani, A., Fabbri, A., Mantovani, G., Mariani, S., Lubrano, C., Poggiogalle, E., Migliaccio, S., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01061-2 · Cited by 283
Insulin resistance and PCOS: chicken or egg?
Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01351-0 · Cited by 209
Self-citationPolycystic ovary syndrome as a metabolic disease
Helvaci, N., & Yildiz, B. O. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 188
Metadata
- Authors
- Tosi, F., Bonora, E., & Moghetti, P.
- Affiliations
- University of Verona (IT)
- Corresponding author
- Moghetti, Paolo
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-13
- Volume
- 32
- Issue
- 12
- Pages
- 2515-2521
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2763794285
- Cited by
- 163
- References
- 26
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 21 · 2023: 24 · 2022: 27 · 2021: 16 · 2020: 10 · 2019: 6 · 2018: 5
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Verona
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- insulin resistance, polycystic ovary syndrome, hyperinsulinemic-euglycemic clamp, HOMA, QUICKI, Matsuda insulin sensitivity index, hyperandrogenism, menstrual disorders, obesity, normal-weight women, diagnostic accuracy, referral bias, hyperinsulinemia
- MeSH terms
- Adult, Body Weight, Female, Glucose Tolerance Test, Homeostasis, Humans, Hyperinsulinism, Insulin Resistance, Obesity, Phenotype, Polycystic Ovary Syndrome, Retrospective Studies, ROC Curve, Glucose Clamp Technique, Cohort Studies, Biomarkers, Hyperandrogenism, Overweight, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.